Regeneron Follows REGEN-COV Revenue Success With Impressive PD-1 Data

Libtayo Showed Efficacy With Chemo In 1L NSCLC

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.